• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Provectus Biopharmaceuticals Inc

+ Add to Watchlist

PVCT:US

0.8300 USD 0.0200 2.35%

As of 20:04:04 ET on 12/19/2014.

Snapshot for Provectus Biopharmaceuticals Inc (PVCT)

Open: 0.8500 Day's Range: 0.8126 - 0.9000 Volume: 476,143
Previous Close: 0.8500 52wk Range: 0.3000 - 6.0300 1-Yr Rtn: -44.67%

Stock Chart for PVCT

No chart data available.
  • PVCT:US 0.8300
  • 1D
  • 1M
  • 1Y
0.8500
Interactive PVCT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PVCT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1900
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 149.65
Shares Outstanding (M) 180.30
30 Day Average Volume 394,795
Price/Book (mrq) 7.6588
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PVCT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PVCT

Provectus Biopharmaceuticals, Inc. researches and develops pharmaceutical products and therapies. The Company develops therapies designed to target and destroy melanoma, liver and breast cancer as well as treat psoriasis and atopic dermatitis.

H Craig DeesChairman/CEOTimothy C ScottPresident
Peter R CulpepperCFO/COO/SecretaryEric A WachterChief Technology Officer
More Company Profile & Key Executives for PVCT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil